Drug susceptibility and treatment response of common urinary tract infection pathogens in children

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 6, 2014, Pages 478-483

  Chen, Pei Chun ^a   Chang, Luan Yin ^a   Lu, Chun Yi ^a   Shao, Pei Lan ^a   Tsai, I Jung ^a   Tsau, Yong Kwei ^a   Lee, Ping Ing ^a   Chen, Jong Ming ^a   Hsueh, Po Ren ^a   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Pathogen; Response; Susceptibility; Urinary tract infection

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALEXIN; CEFAZOLIN; CEFMETAZOLE; CEFTRIAXONE; CEPHALOSPORIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CLINICAL PRACTICE; COLONY FORMING UNIT; DRUG RESPONSE; DRUG SENSITIVITY; ESCHERICHIA COLI INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; TREATMENT RESPONSE; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; CHILD; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PRESCHOOL CHILD; TAIWAN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINARY TRACT INFECTIONS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; TAIWAN; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84908570165     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.07.011     Document Type: Article

References (14)

1. Performance standards for antimicrobial susceptibility testing; 19th informational supplement (CLSI document M100-S19) 2009, Clinical and Laboratory Standards Institute (CLSI), Clinical and Laboratory Standards Institute, Wayne, PA.
2. Performance standards for antimicrobial susceptibility testing; 21st informational supplement (CLSI document M100-S21) 2011, Clinical and Laboratory Standards Institute (CLSI), Clinical and Laboratory Standards Institute, Wayne, PA.
3. Performance standards for antimicrobial susceptibility testing; 20th informational supplement (CLSI document M100-S20) 2010, Clinical and Laboratory Standards Institute (CLSI), Clinical and Laboratory Standards Institute, Wayne, PA.
4. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts K.B. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011, 128:595-610.
5. Infectious Diseases Society of the Republic of China, Medical Foundation in Memory of Dr.Deh-Lin Cheng, Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education, Lee CY's Research Foundation for Pediatric Infectious Diseases and Vaccine Guidelines for antimicrobial therapy of urinary tract infections in Taiwan. J Microbiol Immunol Infect 2000, 33:271-272.
6. Lu K.C., Chen P.Y., Huang F.L., Yu H.W., Kao C.H., Fu L.S., et al. Is combination antimicrobial therapy required for urinary tract infection in children?. J Microbiol Immunol Infect 2003, 36:56-60.
7. Huang C.C., Chen Y.S., Toh H.S., Lee Y.L., Liu Y.M., Ho C.M., et al. Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010. Int J Antimicrob Agents 2012, 40S:S4-S10.
8. Lu P.L., Liu Y.C., Toh H.S., Lee Y.L., Liu Y.M., Ho C.M., et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 2012, 40S:S37-S43.
9. Maraki S., Mantadakis E., Michailidis L., Samonis G. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010. J Microbiol Immunol Infect 2012, 46:202-209.
10. Tseng M.H., Lo W.T., Lin W.J., Teng C.S., Chu M.L., Wang C.C. Changing trend in antimicrobial resistance of pediatric uropathogens in Taiwan. Pediatr Int 2008, 50:797-800.
11. Hoban D.J., Lascols C., Nicolle L.E., Badal R., Bouchillon S., Hackel M., et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 2012, 74:62-67.
12. Kozer E., Rosenbloom E., Goldman D., Lavy G., Rosenfeld N., Goldman M. Pain in infants who are younger than 2 months during suprapubic aspiration and transurethral bladder catheterization: a randomized, controlled study. Pediatrics 2006, 118:e51-e56.
13. El-Naggar W., Yiu A., Mohamed A., Shah V., Manley J., McNamara P., et al. Comparison of pain during two methods of urine collection in preterm infants. Pediatrics 2010, 125:1224-1229.
14. Downs S.M. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999, 103. e54.